It is thought that ACE2 activity may counteract the hypertensive effects of Ang-II in patients with high blood pressure, particularly early in hypertension, meaning that hypertension may increase endogenous ACE2 levels [5,6,27]. The gene discussed is AGT; the disease is Hypertension.